AstraZeneca’s Soriot: UK’s Pharma Policies Have Already Hit Investment
Life Science Strategy Not Being Supported
Pascal Soriot claims the UK is undermining its life sciences sector, and the government needs to support market access and clinical trials in the country or face losing out to competing nations.
